Szela Mary T Insider Trades

Insider Trading History

Track insider trading activity for Szela Mary T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $4.42M 1,077,683 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2k 3,990 shares
$4.55
$4.10
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $235k 1,077,683 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$870 3,990 shares
$0.22
$0.22
Absci
Absci ABSI
Director
Holding Value $208k 21,300 shares
Last Trade
Jun 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$149k 12,900 shares
$11.54
$9.76
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $12.2M 1,077,683 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.3k 3,990 shares
$11.35
$11.35
Absci
Absci ABSI
Director
Holding Value $388k 39,800 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 49,900 shares
$7.34
$9.76
Kura Oncology
Kura Oncology KURA
Director
Holding Value $397k 35,000 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 35,000 shares
$8.77
$11.33
Absci
Absci ABSI
Director
Holding Value $324k 33,200 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$305k 41,600 shares
$7.34
$9.76
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $4.37M 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$103k 39,682 shares
$2.59
$4.10
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $232k 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.65k 39,682 shares
$0.22
$0.22
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $12.1M 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$450k 39,682 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $164k 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.48k 15,944 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.09M 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.4k 15,944 shares
$3.85
$4.10
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.55M 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 15,944 shares
$11.35
$11.35
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.73M 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.5k 4,358 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $168k 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$950 4,358 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.15M 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$18k 4,358 shares
$4.13
$4.10
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $169k 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.65k 30,487 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.17M 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$152k 30,487 shares
$4.99
$4.10
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.78M 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$346k 30,487 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $6.47M 1,578,182 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.75M 675,000 shares
$5.55
$4.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up